 |
BioWorld-Insight-2011-07-11
BioLineRx Trades IPO for ADR To Access Investors, Partners
Public Biotechs Drive Funding Increase in H1 2011 v. H1 2010
Biotech companies raised a total of $13.3 billion in the first half of 2011, reclaiming much of the fundraising ground that was lost when the markets crashed in 2008.